June 15 -- Bloomberg Businessweek's Matthew Campbell reports on GlaxoSmithKline experimenting with grain-size implants that can be bolted directly onto nerves to treat diseases, augmenting or replacing drugs. He speaks with Mark Barton on "Bloomberg Markets."